Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review.

ABSTRACT:

Background

Endemic to the hospital environment, Staphylococcus aureus (S. aureus) is a leading bacterial pathogen that causes deadly infections such as bacteremia and endocarditis. In past viral pandemics, it has been the principal cause of secondary bacterial infections, significantly increasing patient mortality rates. Our world now combats the rapid spread of COVID-19, leading to a pandemic with a death toll greatly surpassing those of many past pandemics. However, the impact of co-infection with S. aureus remains unclear. Therefore, we aimed to perform a high-quality scoping review of the literature to synthesize the existing evidence on the clinical outcomes of COVID-19 and S. aureus co-infection.

Methods

A scoping review of the literature was conducted in PubMed, Scopu

SUBMITTER: Adalbert JR 

PROVIDER: S-EPMC8453255 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature